Zhang Suxiang

チャンモトカ | Zhang Suxiang

Affiliation and department：

Research field (3)： Developmental biology , Systems genomics , Anatomy

Research keywords (4)：シグナル伝達 , 乳がん , 染色体異常 , 発達障害

Papers (8)：

Tomomi Kanazawa, Hiroki Michida, Yuki Uchino, Akari Ishihara, Suxiang Zhang, Sho Tabata, Yutaka Suzuki, Akira Imamoto, Mariko Okada. Cell shape-based chemical screening reveals an epigenetic network mediated by focal adhesions. The FEBS Journal. 2021
Hiroaki Imoto, Suxiang Zhang, Mariko Okada. A Computational Framework for Prediction and Analysis of Cancer Signaling Dynamics from RNA Sequencing Data-Application to the ErbB Receptor Signaling Pathway. Cancers. 2020. 12. 10. 2878-2878
Akira Imamoto, Sewon Ki, Leiming Li, Kazunari Iwamoto, Venkat Maruthamuthu, John Devany, Ocean Lu, Tomomi Kanazawa, Suxiang Zhang, Takuji Yamada, et al. Essential role of the Crk family-dosage in DiGeorge-like anomaly and metabolic homeostasis. Life science alliance. 2020. 3. 2
井元宏明, 岩本一成, 間木重行, 張素香, 岡田眞里子. ErbBシグナル伝達経路と細胞周期の統合数理モデルを用いた細胞応答の予測. 日本生化学会大会プログラム・講演要旨集. 2018. 91回. [2P-260]
Suxiang Zhang, Yuki Fujita, Rieko Matsuzaki, Toshihide Yamashita. Class i histone deacetylase (HDAC) inhibitor CI-994 promotes functional recovery following spinal cord injury article /13/51 /64/60 /38/77. Cell Death and Disease. 2018. 9. 5. 460

ｍore...

Professional career (1)：

Work history (1)：

Association Membership(s) (2)：

THE JAPANESE CANCER ASSOCIATION , THE MOLECULAR BIOLOGY SOCIETY OF JAPAN

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page